The DOI matches its Crossref record.
Cancer prevalence in the United Kingdom: estimates for 2008
Open accessAbstract
BACKGROUND: Identifying and addressing the requirements of cancer survivors is currently a high priority for the NHS, yet little is known about the population of cancer survivors in the United Kingdom. METHODS: Data from cancer registries in England, Northern Ireland, Scotland and Wales were analysed to provide limited-duration prevalence estimates for 2004. Log-linear regression models were used to extend these to complete prevalence estimates. Trends in prevalence from 2000 to 2004 were used to project complete prevalence estimates forward from 2004 to 2008. RESULTS: We estimated that in total, there were 2 million cancer survivors in the United Kingdom at the end of 2008, approximately 3% of the population overall and 1 in 8 of those aged 65 years and more. Prostate and female breast cancers were the most prevalent. The number of cancer survivors is increasing by approximately 3% each year. Estimates are also provided by time since diagnosis. CONCLUSION: These estimates are the most up-to-date available, and as such will be useful for statutory and voluntary sector organisations that are responsible for planning and providing treatment and support to cancer survivors in the United Kingdom.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 8
- Brown ML, Riley GF, Potosky AL, Etzioni RD (1999) Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care 37: 1249–1259 · DOI · Paper page
- Capocaccia R, De Angelis R (1997) Estimating the completeness of prevalence based on cancer registry data. Stat Med 16: 425–440 · DOI
- Capocaccia R, Gatta G, Chessa E, Valente F (1999) The EUROCARE-2 study. IARC Sci Publ 151: 1–40
- Evans HS, Moller H (2003) Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol 43: 337–341 · doi:10.1016/s0302-2838(03)00085-x
- Forman D, Stockton D, Moller H, Quinn M, Babb P, De Angelis R, Micheli A (2003) Cancer prevalence in the UK: results from the EUROPREVAL study. Ann Oncol 14: 648–654 · DOI
- Moller T, Anderson H, Aareleid T, Hakulinen T, Storm H, Tyggvadottir L, Corazziari I, Mugno E (2003) Cancer prevalence in Northern Europe: the EUROPREVAL study. Ann Oncol 14: 946–957 · DOI
- Phillips N, Coldman A, McBride ML (2002) Estimating cancer prevalence using mixture models for cancer survival. Stat Med 21: 1257–1270 · doi:10.1002/sim.1101
- Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ, Steward J, Brenner H, Esteve J, Sullivan R, Coleman MP (2008) Cancer survival in England and Wales at the end of the 20th century. Br J Cancer 99 (Suppl 1): S2–S10 · DOI
Cited by
Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu042 · Cited by 1,165
Blaney, J. M., Lowe‐Strong, A., Rankin‐Watt, J., Campbell, A., & Gracey, J. H. (2013) · Psycho-Oncology · doi:10.1002/pon.2072 · Cited by 259
Deckx, L., van den Akker, M., & Buntinx, F. (2014) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2014.05.002 · Cited by 206
Primary Health and Supportive Care Needs of Long-Term Cancer Survivors: A Questionnaire Survey
Harrison, S. E., Watson, E. K., Ward, A. M., Khan, N. F., Turner, D., Adams, E., Forman, D., Roche, M. F., & Rose, P. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5167 · Cited by 176
Using technology to deliver cancer follow-up: a systematic review
Dickinson, R., Hall, S., Sinclair, J. E., Bond, C., & Murchie, P. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-311 · Cited by 146
Metadata
- Authors
- Maddams, J., Brewster, D., Gavin, A., Steward, J., Elliott, J., Utley, M., & Møller, H.
- Venue
- British Journal of Cancer
- Published
- 2009-06-30
- Volume
- 101
- Issue
- 3
- Pages
- 541-547
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2129820723
- Cited by
- 244
- References
- 0
- FWCI
- 11.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer prevalence in the United Kingdom: estimates for 2008. https://app.cochat.ai/papers/10.1038/sj.bjc.6605148
- The paper
- Maddams, J., Brewster, D., Gavin, A., Steward, J., Elliott, J., Utley, M., & Møller, H. (2009). Cancer prevalence in the United Kingdom: estimates for 2008. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6605148
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
